The challenges of carbapenemase-producing Enterobacteriaceae and infection prevention: protecting patients in the chaos

Infect Control Hosp Epidemiol. 2013 Jul;34(7):730-9. doi: 10.1086/671003. Epub 2013 May 22.

Authors

Patrice Savard¹, Karen C Carroll, Lucy E Wilson, Trish M Perl

Affiliation

¹ Division of Infectious Diseases, Department of Medicine, Johns Hopkins University, Baltimore, Maryland 21287, USA. patrice.savard.chum@ssss.gouv.qc.ca

PMID: 23739078
DOI: 10.1086/671003

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Anti-Bacterial Agents / pharmacology
Anti-Bacterial Agents / therapeutic use
Bacterial Proteins / biosynthesis
Carbapenems / pharmacology
Carbapenems / therapeutic use
Cross Infection / drug therapy
Cross Infection / microbiology
Cross Infection / prevention & control
Enterobacteriaceae / drug effects*
Enterobacteriaceae / enzymology
Enterobacteriaceae Infections / drug therapy
Enterobacteriaceae Infections / epidemiology
Enterobacteriaceae Infections / microbiology
Enterobacteriaceae Infections / prevention & control*
Humans
Patient Isolation
beta-Lactam Resistance
beta-Lactamases / biosynthesis

Substances

Anti-Bacterial Agents
Bacterial Proteins
Carbapenems
beta-Lactamases
carbapenemase